Premium
Survival outcomes in locally advanced cutaneous squamous cell carcinoma presenting with clinical perineural invasion alone
Author(s) -
Hazim Antonious Z.,
Reed Clay T.,
Price Katharine A.,
Foote Robert L.,
Ma Daniel J.,
NebenWittich Michelle,
DeLone David R.,
Jenkins Sarah M.,
Smith Carin Y.,
Chintakuntlawar Ashish V.
Publication year - 2021
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/hed.26661
Subject(s) - medicine , perineural invasion , chemoradiotherapy , radiation therapy , retrospective cohort study , surgery , oncology , cancer
Background Cutaneous squamous cell carcinomas (CSCC) involving the head and neck are common, but initial presentation or recurrence limited to the cranial nerves is rare. Methods We conducted a retrospective study of 21 patients with clinical perineural invasion (PNI) from CSCC and no measurable disease by RECIST 1.1. Patients treated with radiotherapy or chemoradiotherapy were included. Results The median time from symptom onset until diagnosis was 13.0 months (2.6–83.1). All patients received radiotherapy. Fourteen received concurrent systemic therapy. The median follow‐up time was 30.5 months (1.1–106.0). Ten patients recurred, with the majority being locoregional. The 2‐year overall survival rate was 85%. The median progression‐free survival (PFS) was 21.5 months with an estimated 2‐year PFS of 44.5% (95%CI: 22.3–66.8). Conclusions CSCCs with clinical PNI alone are difficult to diagnose and can have a long interval between appearance of symptoms and diagnosis. They can successfully be treated with chemoradiotherapy. However, many patients still suffer from locoregional recurrences.